Baxter International (BAX)
(Delayed Data from NYSE)
$45.69 USD
+0.55 (1.22%)
Updated Jan 31, 2023 04:00 PM ET
After-Market: $45.71 +0.02 (0.04%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum B VGM
Company Summary
Headquartered in Deerfield, IL, Baxter International Inc. is a global medical technology company. However, the company spun off its biopharmaceuticals segment into an independent entity – Baxalta Inc. Following the spinoff, the company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions.
Baxter has been reporting through six revenue segments. Renal Care (32% of net sales in 2020), Medication Delivery (23%), Pharmaceuticals (18.2%), Clinical Nutrition (7.9%), Advanced Surgery (7.6%), Acute Therapies (6.3%) and Other (4.4%).
Baxter’s Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (...
Company Summary
Headquartered in Deerfield, IL, Baxter International Inc. is a global medical technology company. However, the company spun off its biopharmaceuticals segment into an independent entity – Baxalta Inc. Following the spinoff, the company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions.
Baxter has been reporting through six revenue segments. Renal Care (32% of net sales in 2020), Medication Delivery (23%), Pharmaceuticals (18.2%), Clinical Nutrition (7.9%), Advanced Surgery (7.6%), Acute Therapies (6.3%) and Other (4.4%).
Baxter’s Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. Pharmacy Solutions (IPS) mainly includes premixed and oncology drug platforms, nutrition products and pharmacy compounding services. Cyclophosphamide is a part of this division. Surgical Care includes inhaled anesthesia products as well as biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. Other segment primarily generates revenues from the company’s pharmaceutical partnering business.
2021 at a Glance: Baxter reported net revenues of $12.78 billion in 2021, up 10% year over year on a reported basis. Adjusted earnings of $3.61 per share, up 17% year over year.
General Information
Baxter International Inc
One Baxter Parkway DF2-1W
Deerfield, IL 60015
Phone: 224-948-2000
Fax: 224-948-1813
Email: global_corp_investor_relations@baxter.com
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 12/31/2022 |
Earnings Date | 2/9/2023 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.94 |
Current Year EPS Consensus Estimate | 3.56 |
Estimated Long-Term EPS Growth Rate | 5.60 |
Earnings Date | 2/9/2023 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 45.14 |
52 Week High | 89.70 |
52 Week Low | 43.25 |
Beta | 0.61 |
20 Day Moving Average | 6,148,863.00 |
Target Price Consensus | 58.08 |
4 Week | -11.44 |
12 Week | -13.76 |
YTD | -11.44 |
4 Week | -15.37 |
12 Week | -18.29 |
YTD | -15.37 |
Shares Outstanding (millions) | 504.12 |
Market Capitalization (millions) | 22,756.01 |
Short Ratio | NA |
Last Split Date | 5/31/2001 |
Dividend Yield | 2.57% |
Annual Dividend | $1.16 |
Payout Ratio | 0.32 |
Change in Payout Ratio | 0.03 |
Last Dividend Payout / Amount | 12/1/2022 / $0.29 |
Fundamental Ratios
P/E (F1) | 12.68 |
Trailing 12 Months | 12.33 |
PEG Ratio | 2.26 |
vs. Previous Year | -19.61% |
vs. Previous Quarter | -5.75% |
vs. Previous Year | 16.96% |
vs. Previous Quarter | 0.72% |
Price/Book | 4.08 |
Price/Cash Flow | 8.29 |
Price / Sales | 1.54 |
12/31/22 | NA |
9/30/22 | 22.65 |
6/30/22 | 21.75 |
12/31/22 | NA |
9/30/22 | 5.88 |
6/30/22 | 6.63 |
12/31/22 | NA |
9/30/22 | 2.11 |
6/30/22 | 2.01 |
12/31/22 | NA |
9/30/22 | 1.38 |
6/30/22 | 1.33 |
12/31/22 | NA |
9/30/22 | 12.57 |
6/30/22 | 13.77 |
12/31/22 | NA |
9/30/22 | -16.12 |
6/30/22 | 7.12 |
12/31/22 | NA |
9/30/22 | -15.56 |
6/30/22 | 7.91 |
12/31/22 | NA |
9/30/22 | 11.07 |
6/30/22 | 17.68 |
12/31/22 | NA |
9/30/22 | 3.64 |
6/30/22 | 3.58 |
12/31/22 | NA |
9/30/22 | 2.90 |
6/30/22 | 1.83 |
12/31/22 | NA |
9/30/22 | 74.33 |
6/30/22 | 64.64 |